Colorectal Cancer Clinical Trials in San Diego, CA

Colorectal Cancer Clinical Trials in San Diego, CA

View the best 10 colorectal cancer medical studies in San Diego, California. Access promising new therapies by applying to a San Diego-based Colorectal Cancer clinical trial.

Trials in San Diego, California

Here are the top 10 medical studies for colorectal cancer in San Diego, California

Image of Kaiser Permanente Orange County Anaheim/Irvine Medical Center Oncology Clinics in Anaheim, United States.

Embedded primary care in cancer survivorship model

Behavioural Intervention

Recruiting1 award7 criteria
This trial looks at two different ways of providing care to cancer survivors to see which is more effective.
Image of Alaska Oncology in Anchorage, United States.

Bevacizumab +3 More

Monoclonal Antibodies

Recruiting1 awardPhase 1 & 2
This trial studies a combo therapy for colorectal cancer, to see if it's safe and effective.
Image of Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro in Jonesboro, United States.

Oxaliplatin +4 More

Chemotherapy

Recruiting2 awardsPhase 3
This trial is testing a combination of chemotherapy drugs, bevacizumab, and atezolizumab to treat patients with metastatic colorectal cancer.
Image of Anchorage Associates in Radiation Medicine in Anchorage, United States.

Leucovorin Calcium, Fluorouracil, Oxaliplatin

Chemotherapy

Recruiting2 awardsPhase 3
This trial is testing whether adding atezolizumab to standard chemotherapy works better than chemotherapy alone for patients with stage III colon cancer who have a specific genetic defect. The chemotherapy drugs aim to kill cancer cells, while atezolizumab helps the immune system attack the cancer. Researchers hope this combination will improve survival rates and quality of life for these patients.
Image of Alabama Oncology, Bruno Cancer Center in Birmingham, United States.

mFOLFOX6 Regimen +3 More

Small Molecule

Recruiting2 awardsPhase 3
This trial is testing a new treatment for patients with colorectal cancer. The treatment combines two drugs that work together to block cancer growth and prevent its spread. One of the drugs has shown promise in treating other types of cancer as well.
Image of Sarah Cannon Research Institute at HealthONE in Denver, United States.

P-MUC1C-ALLO1 CAR-T cells

CAR T-cell Therapy

Recruiting1 awardPhase 1
This trial tests a new therapy using modified immune cells in adults with advanced cancers. The treatment aims to target and destroy cancer cells with a specific marker found in various cancers, including breast cancer.
Image of South Texas Accelerated Research Therapeutics, LLC in San Antonio, United States.

FMC-376

Monoclonal Antibodies

Recruiting1 awardPhase 1 & 2
This trial will test a drug called FMC-376 in patients with advanced solid tumors that have a specific genetic mutation. The trial will have three parts to determine the safety and effectiveness of the drug at
Image of University of California Davis in Sacramento, United States.

Tisotumab Vedotin

Antibody-Drug Conjugate

Recruiting1 awardPhase 2
This trial will study tisotumab vedotin to find out whether it is an effective treatment for certain solid tumors and what side effects (unwanted effects) may occur. There are four parts to this study.
Image of University of California San Diego in La Jolla, United States.

Cologuard +1 More

Cancer Screening Test

Recruiting1 award1 criteria
"This trial will compare two stool-based screening tests, Cologuard and the fecal immunochemical test (FIT), in adults aged 45-49 at the University of California San Diego Health system
Image of MD Anderson Cancer Center - Oncology in Houston, United States.

M9140

Anti-tumor Antibody-drug Conjugate

Recruiting1 awardPhase 1
This trial is testing a new drug called M9140 to see if it is safe and effective for patients with advanced solid tumors. Researchers will study how the drug behaves in the body, how well patients can tolerate it, and if it shows any signs of fighting the cancer.

Phase 3 Trials

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.